samedan logo

 
 
spacer
home > pmps > winter 2008 > optimising profitability potential
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Optimising Profitability Potential

Andre Grigjanis at IBS Pharma tells us how to gain increased profitability with inventory optimisation

One of the largest capital expenses for pharmaceutical wholesalers is stock. Finding a balance – ensuring that products are available when customers need them, yet do not become an excess product – is critical for a successful business. However, most companies make these decisions without looking at the full picture. They don’t consider how to plan accurately for demand on the basis of detailed purchasing histories, or how to handle returns effectively. An inventory optimisation solution is designed to help companies overcome these issues in order to enhance customer service and lower operational costs.

WHAT IS INVENTORY OPTIMISATION?

Inventory optimisation tools help companies to make reliable decisions regarding product replenishment. Making the correct decisions raises efficiency and profitability by improving the forecasting of future demand and by creating a more economical stock holding. The physical distribution network is the basis for an effective inventory and supply chain management solution. Inventory optimisation defines a unique multi-level distribution network for each product, covering where the product is stored: either at an external supplier or within internal production or warehouse locations. Replenishment recommendations created by an inventory optimisation system can help companies decide when to buy, produce or ship goods between warehouses, thereby optimising the total inventory situation.

All pharmaceutical wholesalers have fastmoving products, such as aspirins, that they need to be available all the time. However, there may be some specific drugs that are required much more rarely. They may be expensive, but if a customer asks for them and they are not available, the customer is not going to wait. A dedicated solution for optimising inventories helps to ensure that the right products are available when and where they are needed. In addition, by automating many of the procedures required for effective inventory management, the people who deal with purchasing can concentrate on more profitable items.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
Andre Grigjanis is Vice President, Pharma at IBS. After spending several years in international IT services for IBM and other software companies, for the last seven years he has concentrated on business development, business processes and the supply chain within the pharmaceutical industry. His experience has given him an excellent overview of trends in the pharmaceutical distribution business as well as current and future demands. As Vice President, Pharma, he represents the IBS Group at IFPW (International Federation of Pharmaceutical Wholesalers) and GIRP (European Association of Pharmaceutical Full-line Wholesalers) meetings and congresses. Andre has a Master’s Degree in Electronic Engineering and Economics
spacer
Andre Grigjanis
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Key milestone in molded glass: SGD Pharma elevates Type I offering with three tailored product and service solutions

Puteaux Cedex, FRANCE – 23rd March: SGD Pharma, a leading supplier of glass primary packaging in the pharmaceutical industry and global expert in Type I molded glass, introduces an industry first offering of Type I molded glass vials. These market-driven value propositions represent the latest step in SGD Pharma’s ongoing improvements to its product offers and services. According to their specific business and parenteral drug requirements, Pharma and Biotech players would not only benefit from SGD Pharma’s enhanced high quality and reliable products, but also from an extended offer, ranging from Total Cost of Ownership (TCO) optimization to the highest levels of services.
More info >>

White Papers

Convergence in the Pharmaceutical Market

PCI Pharma Services

Convergence is currently playing a large part in the growth of the pharmaceutical market. The need for convergence is due to many factors including the declining economy and high competition within the sector. There are many convergences within this sector to date; these include the convergence of food based products with medical and health products and the convergence of prescription drugs to over the counter (OTC) products. Although convergence is helping the pharmaceutical industry expand and develop, it also poses some challenges; these include the regulatory outlook and counterfeiting.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement